Letaplimab represents a unique therapeutic strategy for treating complement-mediated illnesses. This biologic targets the C1q protein, a critical factor of the complement system, aiming to disrupt its initial https://lewisggwv501058.blog-gold.com/58588656/letaplimab-a-innovative-medical-method